SCHEMBL16205508

SCHEMBL16205508

Cc1nc(Cl)cc2c(C(=O)/C=C/N(C)C)c[nH]c12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 9/20 0.44
▸ HPGD P15428 3/20 0.44
▸ CYP1A2 P05177 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ PIM1 P11309 2/20 0.40
▸ RAB9A P51151 6/20 0.38
▸ HTT P42858 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ RECQL P46063 2/20 0.38
▸ ALDH1A1 P00352 8/20 0.38
▸ GAA P10253 3/20 0.38
▸ NPC1 O15118 3/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16205349 0.78 BRPF1 (0.47) HPGDCYP1A2CYP2C19RAB9ALMNA
SCHEMBL21024318 0.74 ALDH1A1 (0.35) HPGDRAB9ALMNAALDH1A1GAA
SCHEMBL19644386 0.74 NR4A2 (0.54) MAPTHPGDRAB9ALMNAALDH1A1
SCHEMBL4301614 0.71 CSNK2A1 (0.56) HPGDCYP1A2CYP2C19ALOX12HTT
SCHEMBL5762528 0.70 MAPT (0.59) MAPTHPGDCYP1A2CYP2C19ALOX12
SCHEMBL5762531 0.70 MAPT (0.59) MAPTHPGDCYP1A2CYP2C19ALOX12
SCHEMBL19657598 0.69 NR4A2 (0.35) SMN1; SMN2KDM4E
SCHEMBL19657777 0.68 — —
SCHEMBL13100627 0.67 HTT (0.44) MAPTHPGDCYP1A2CYP2C19ALOX12
SCHEMBL2235 0.67 NPC1 (0.62) MAPTHPGDPIM1RAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643964-B2 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer JANSSEN PHARMACEUTICA NV (BE) 2017-05-09 — — US disclosed
WO-2014174021-A1 3-(2-AMINOPYRIMIDIN-4-YL)-5-(3-HYDROXYPROPYNYL)-1H-PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS NIK INHIBITORS FOR THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA NV (BE) 2014-10-30 — — WO disclosed
Send feedback